Sustainable and "Green" Pharmaceutical Manufacturing
In 2026, French outsourcing partners are distinguished by their focus on Green Chemistry and decarbonized manufacturing. Under strict EU environmental regulations, French CDMOs have integrated renewable energy and solvent-recovery systems into their production lines.
Outsourcing to France allows pharmaceutical companies to improve their ESG (Environmental, Social, and Governance) scores. These "Green CDMOs" provide detailed carbon-footprint reporting for every batch produced, a service that is becoming a standard requirement for major pharmaceutical tenders in Europe.
1 View